Use of Total Cerebral Blood Flow as an Imaging Biomarker of Known Cardiovascular Risks

Abstract

Reduced cerebral blood flow seems to be a correlate of vascular disease risk factors associated with cardiometabolic dysregulation. Cerebral blood flow may provide a valid imaging biomarker for cardiovascular risk.